A Multicenter Randomized Controlled Trial of Pharmacists in Medication Evaluation and Management Mode Exploration of Atrial Fibrillation Patients Oral Anticoagulants

Seamless pharmaceutical care and management for patients with chronic diseases

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033697

Enrollment

Unknown

Registered

2020-06-09

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

intervention group:pharmaceutical care

control group:conventional care

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosis of atrial fibrillation; 2. Anticoagulation therapy lasts at least two months; 3. Voluntarily participate and agree to cooperate with relevant requirements of the research program; 4. Aged >= 18 years.

Exclusion criteria

Exclusion criteria: 1. Have severe mental illness or mental retardation; 2. Have communication difficulty.

Design outcomes

Primary

Measure	Time frame
Medication compliance score;Bleeding related adverse events;Embolism-related adverse events;score of drug cognitive ability;	—

Secondary

Measure	Time frame
condition of chronic disease;	—

Countries

China

Contacts

Public ContactXia Wenbin

Beijing Chuiyangliu Hospital

cylyyyjk@126.com+86 010-67700372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026